Stock NGEN NERVGEN PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications NervGen Pharma Corp.

Equities

NGEN

CA64082X2032

Delayed Toronto S.E.
Other stock markets
 19:25:27 16/05/2024 BST 		5-day change 1st Jan Change
1.95 CAD -7.14% Intraday chart for NervGen Pharma Corp. -2.97% -27.41%
04-17 NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update MT
04-17 NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. NGEN Stock
  4. News NervGen Pharma Corp.
  5. Official Publications